} ?>
(Yicai Global) Jan.21 -- iKang Healthcare Group, China's first private healthcare provider to go public, has gotten its stock delisted from the Nasdaq. Buyers look to revamp the target firm's technology to make the company profitable again.
The investors, including Alibaba's e-commerce unit Taobao China Holding, Treasure Cottage and Yunfeng IK Co-invest, which is a joint venture between Suning.Com and Jack Ma's Yunfeng Capital, paid cumulatively about USD1.1 billion to take iKang private, the Beijing-based healthcare firm said in a statement on Jan. 18.
"Today is a new milestone," Zhang Ligang, the president of iKang. "We are honored to receive support from top investors and strategic partners." The stock [NASDAQ: KANG] ended trading 0.049 percent down at USD20.53 on Jan. 18.
Taobao and Treasure Cottage will indirectly hold a 23.8 percent stake in iKang, Yunfeng IK Co-invest will have 8.2 percent of the equity, and Suning International Group 3.4 percent upon transaction. The remaining USD360 million worth of equity will be shared between Chairman and Chief Executive Zhang Ligang, Vice Chairman He Boquan, and other affiliates.
The buyers recognized the challenges brought about by the current imbalance between supply and demand, private equity fund Yunfeng Fund said on behalf of the investors, adding that technology and innovation will help drive the development of the company's business. iKang made USD560 million in revenues in 2017, and logged USD17 million in losses.
iKang accepted a takeover offer to privatize its business, initiated by Yunfeng Capital and Alibaba Group Holding, it said in a statement last March. The deal priced the equity at USD41.2 per common stock or USD20.6 per American depositary share.
iKang will use artificial intelligence to enhance the three major areas of physical examination, post-inspection management and treatment, it said in a statement a month ago. The company will maintain a steady growth and will not overexpand, Zhang said at that time.
Founded in 2004, iKang offers physical examination services mostly for corporations in over 30 cities across China, as of November 2018. The firm got listed in the US in September 2014.
Editor: Emmi Laine